# Silicon Laboratories share price today (Silicon Laboratories Inc., SLAB)

> Silicon Laboratories Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. SLAB · Technology · Semiconductors · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/slab

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $222.34 (+69.6% in a year)
- P/E: 67.1× (higher than 62% of the last 2.1 years)
- Revenue (Jul 2026): $228 M (+18.3% on a year ago)
- Profit (Jul 2026): −$10.6 M
- Operating margin: −4.7% (+7.2 points on a year ago)
- ROE: −6%, FY26
- ROIC: −6.4%, against a 11.6% cost of capital: −18.0 points
- Profit that came in as cash: −1%, last 2 years

The main question: profits are rising, but only −1% of the last 2 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Silicon Laboratories share price today? Silicon Laboratories Inc.'s share price was $222.34 at the close on 3 November 2026. It has been rising for 49 weeks. That is 5.1% above its average price over the last 200 trading days. In the last 52 weeks it traded between $121 and $223, and at that close it was at the high of that range. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 2 weeks in a row. Over the last 10 years the share price moved +349% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Silicon Laboratories pay? Silicon Laboratories Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Silicon Laboratories on? Silicon Laboratories is on one of our US lists: US tech stocks. [US tech stocks](https://www.sectoralpha.in/us-tech-stocks)

## Is Silicon Laboratories profitable? Silicon Laboratories Inc. posted a net loss of $10.6 M in the Jul 2026 quarter. The full FY26 year was a loss of $64.9 M. That loss is 4.6% of the quarter's revenue. The same quarter a year earlier lost $21.8 M. 11 of the last 12 reported quarters were loss-making. ## How much revenue does Silicon Laboratories make, and is it growing? Silicon Laboratories Inc. reported $228 M of revenue in the Jul 2026 quarter, +18.3% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 4 years it has grown 2.1% a year on average. The last full year, FY26, came in at $785 M. The last four reported quarters add to $856 M. FY26 revenue was $785 M, +34.3% on the year before. Recent pace: the last four quarters grew +20.7% on average, against 2.1% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +21.7%, against +25.6% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does Silicon Laboratories keep? Silicon Laboratories Inc.'s operating margin was −4.7% in the Jul 2026 quarter, 7.2 percentage points higher than the same quarter a year ago. Across 5 years it has been between −28.3% and 11.6%. The latest quarter is within that range. Why the margin moved: operating margin changed +7.2 percentage points on the year while gross margin changed +5.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Silicon Laboratories' profit turning into cash? Over the last 2 years Silicon Laboratories Inc.'s operations used more cash than they brought in, so cash conversion was −1%, a gap worth watching. In FY26 it brought in $95.7 M of operating cash against −$64.9 M of profit. After $29.9 M of spending on assets, $65.8 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Silicon Laboratories' cash go? Silicon Laboratories Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $64.0 M on assets over the last 3 years. Averaged over those years that is 2.7% of FY26 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $64.0 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Silicon Laboratories' P/E ratio, and how does it compare with its own history? Silicon Laboratories Inc.'s P/E is 67.1×, in the middle of its own history: higher than 62% of past readings. Its usual P/E (the middle reading) is 64.3×, over 2.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Silicon Laboratories business getting better or worse? Silicon Laboratories Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Silicon Laboratories earn on its capital? Silicon Laboratories Inc. earned a ROE of −6% in FY26. That is up from a low of −18% in FY24. Its return on capital used (ROIC) is 18.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −8.3% net margin and 0.62× asset turnover (sales divided by assets). Why the return is what it is (FY26): a −8.3% net margin × 0.62× asset turnover × 1.16× leverage (assets divided by equity) ≈ −6.0% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −6.4% − 11.6% = −18.0 percentage points. The 11.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −6.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at −10.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Silicon Laboratories have too much debt? Silicon Laboratories Inc. has total debt of $24.0 M against shareholder equity of $1.1 B as of Jan 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 0.22 in FY22 to 0.02 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Silicon Laboratories shareholding pattern? 5.5% of Silicon Laboratories Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Silicon Laboratories from balance-sheet trouble? For Silicon Laboratories Inc., the Z-score is 22.91. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 22.91 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Silicon Laboratories rank in its industry? 49.0 out of 100, rank 13 of 27 in Semiconductors, with 58% of the evidence available. Silicon Laboratories Inc. scores 49.0 out of 100 against the 27 companies it is compared with in Semiconductors, ranking 13. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 20.5 + 3.1 + 9.8 + 15.6 = 49. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Silicon Laboratories compared with? Silicon Laboratories ranks 13 of 27 Semiconductors companies on the 4-Factor Sector Score, with 49.0 out of 100. 1. [Texas Instruments Incorporated](https://www.sectoralpha.in/us/stocks/txn) TXN · turning · Most evidence points up · 85% evidence 79.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.4/35 · Revenue 20.3% · Profit 41% · Operating margin change 10.8 points · 95% evidence Capital efficiency 20.6/25 · ROCE 25.2% · Operating margin 47.5% · 76% evidence Valuation 14.1/20 · P/E 36.2× · PEG 0.89 · 65% evidence Relative strength 19.0/20 · Lead over its industry 15.7% · Lead over S&P 500 22.3% · 1 year 94.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 25.4 + 20.6 + 14.1 + 19 = 79.1 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Micron Technology, Inc.](https://www.sectoralpha.in/us/stocks/mu) MU · quiet · Most evidence points up · 75% evidence 76.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.9/35 · Revenue 100% · Profit 100% · Operating margin change 48.4 points · 95% evidence Capital efficiency 19.4/25 · ROCE 59% · Operating margin 80.7% · 76% evidence Valuation 11.4/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 14.8/20 · Lead over its industry 26.2% · Lead over S&P 500 26.1% · 1 year 259.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 30.9 + 19.4 + 11.4 + 14.8 = 76.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Analog Devices, Inc.](https://www.sectoralpha.in/us/stocks/adi) ADI · turning · Most evidence points up · 85% evidence 73.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.6/35 · Revenue 33.6% · Profit 100% · Operating margin change 10.9 points · 95% evidence Capital efficiency 14.7/25 · ROCE 11.6% · Operating margin 39.5% · 76% evidence Valuation 11.9/20 · P/E 43.3× · PEG 1.33 · 65% evidence Relative strength 18.1/20 · Lead over its industry 6% · Lead over S&P 500 13.5% · 1 year 83.7% · 100% evidence · 3 of 12 weeks ahead Exact sum: 28.6 + 14.7 + 11.9 + 18.1 = 73.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [NVIDIA Corporation](https://www.sectoralpha.in/us/stocks/nvda) NVDA · quiet · Most evidence points up · 85% evidence 67.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.6/35 · Revenue 83.4% · Profit 100% · Operating margin change 5.4 points · 95% evidence Capital efficiency 21.6/25 · ROCE 71.3% · Operating margin 66.2% · 76% evidence Valuation 15.1/20 · P/E 26× · PEG 0.77 · 65% evidence Relative strength 10.4/20 · Lead over its industry -9.2% · Lead over S&P 500 -1.2% · 1 year 9.9% · 100% evidence · 4 of 12 weeks ahead Exact sum: 20.6 + 21.6 + 15.1 + 10.4 = 67.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Advanced Micro Devices, Inc.](https://www.sectoralpha.in/us/stocks/amd) AMD · losing its lead · Most evidence points up · 71% evidence 65.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Revenue 39.5% · Profit 100% · Operating margin change 19 points · 83% evidence Capital efficiency 11.1/25 · ROCE 9% · Operating margin 17.3% · 76% evidence Valuation 9.2/20 · P/E 132.2× · PEG n/a · 15% evidence Relative strength 17.6/20 · Lead over its industry 22.8% · Lead over S&P 500 24.8% · 1 year 107.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 27.2 + 11.1 + 9.2 + 17.6 = 65.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [NXP Semiconductors N.V.](https://www.sectoralpha.in/us/stocks/nxpi) NXPI · turning · Evidence leans up · 81% evidence 63.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.6/35 · Revenue 8.8% · Profit 38.5% · Operating margin change 4.6 points · 83% evidence Capital efficiency 17.1/25 · ROCE 16.2% · Operating margin 30.4% · 76% evidence Valuation 15.7/20 · P/E 23.5× · PEG 0.59 · 65% evidence Relative strength 13.9/20 · Lead over its industry -3.7% · Lead over S&P 500 4% · 1 year 28.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.6 + 17.1 + 15.7 + 13.9 = 63.3 · What this means: Relative strength against the index is 4%, and revenue and profit growth are weak. 7. [Broadcom Inc.](https://www.sectoralpha.in/us/stocks/avgo) AVGO · quiet · Evidence leans up · 85% evidence 62.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.2/35 · Revenue 48.7% · Profit 100% · Operating margin change 16.1 points · 95% evidence Capital efficiency 20.4/25 · ROCE 26% · Operating margin 54.3% · 76% evidence Valuation 5.8/20 · P/E 48.4× · PEG 5.06 · 65% evidence Relative strength 5.6/20 · Lead over its industry -20.3% · Lead over S&P 500 -12.9% · 1 year -5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 30.2 + 20.4 + 5.8 + 5.6 = 62 · What this means: Earnings are strong; relative strength in its sector is -20.3% and the one-year return is -5%. 8. [Monolithic Power Systems, Inc.](https://www.sectoralpha.in/us/stocks/mpwr) MPWR · quiet · Evidence leans up · 81% evidence 56.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Revenue 28.6% · Profit -51.8% · Operating margin change 6.2 points · 83% evidence Capital efficiency 19.7/25 · ROCE 22.4% · Operating margin 31% · 76% evidence Valuation 5.6/20 · P/E 84.4× · PEG 3.48 · 65% evidence Relative strength 11.7/20 · Lead over its industry -4.5% · Lead over S&P 500 2% · 1 year 38.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 19.2 + 19.7 + 5.6 + 11.7 = 56.2 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 9. [Qorvo, Inc.](https://www.sectoralpha.in/us/stocks/qrvo) QRVO · Too little evidence to rank firmly · 51% evidence 54.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/43.75 · Revenue -0.2% · Profit 100% · Operating margin change 11.6 points · 83% evidence Capital efficiency 14.3/31.25 · ROCE 12.1% · Operating margin 15.8% · 76% evidence Valuation 14.1/25 · P/E 20.7× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 26 + 14.3 + 14.1 = 54.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 10. [Microchip Technology Incorporated](https://www.sectoralpha.in/us/stocks/mchp) MCHP · quiet · Evidence leans up · 74% evidence 52.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.0/35 · Revenue 20.9% · Profit n/a · Operating margin change 19 points · 62% evidence Capital efficiency 9.3/25 · ROCE 6.3% · Operating margin 24% · 76% evidence Valuation 10.9/20 · P/E 134.6× · PEG 1.29 · 65% evidence Relative strength 9.6/20 · Lead over its industry -9.5% · Lead over S&P 500 -2.6% · 1 year 38.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23 + 9.3 + 10.9 + 9.6 = 52.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Astera Labs, Inc.](https://www.sectoralpha.in/us/stocks/alab) ALAB · quiet · Evidence leans up · 71% evidence 52.8 out of 100 Growth Capital Valuation Relative
12. [Semtech Corporation](https://www.sectoralpha.in/us/stocks/smtc) SMTC · losing its lead · Evidence leans up · 67% evidence 51.7 out of 100 Growth Capital Valuation Relative
13. Silicon Laboratories Inc. this page SLAB · turning · Too little evidence to rank firmly · 58% evidence 49.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue n/a · Profit n/a · Operating margin change 7.2 points · 45% evidence Capital efficiency 3.1/25 · ROCE -3.8% · Operating margin -4.7% · 76% evidence Valuation 9.8/20 · P/E 72.8× · PEG n/a · 15% evidence Relative strength 15.6/20 · Lead over its industry 0.9% · Lead over S&P 500 7.9% · 1 year 75.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 3.1 + 9.8 + 15.6 = 49 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 14. [QUALCOMM Incorporated](https://www.sectoralpha.in/us/stocks/qcom) QCOM · turning · Evidence leans down · 81% evidence 48.8 out of 100 Growth Capital Valuation Relative
15. [Skyworks Solutions, Inc.](https://www.sectoralpha.in/us/stocks/swks) SWKS · breaking out · Evidence leans down · 64% evidence 48.7 out of 100 Growth Capital Valuation Relative
16. [Credo Technology Group Holding Ltd](https://www.sectoralpha.in/us/stocks/crdo) CRDO · quiet · Evidence leans down · 75% evidence 47.9 out of 100 Growth Capital Valuation Relative
17. [ON Semiconductor Corporation](https://www.sectoralpha.in/us/stocks/on) ON · quiet · Too little evidence to rank firmly · 56% evidence 46.4 out of 100 Growth Capital Valuation Relative
18. [MACOM Technology Solutions Holdings, Inc.](https://www.sectoralpha.in/us/stocks/mtsi) MTSI · quiet · Evidence leans down · 68% evidence 45.9 out of 100 Growth Capital Valuation Relative
19. [Marvell Technology, Inc.](https://www.sectoralpha.in/us/stocks/mrvl) MRVL · losing its lead · Evidence leans down · 67% evidence 44.7 out of 100 Growth Capital Valuation Relative
20. [Lattice Semiconductor Corporation](https://www.sectoralpha.in/us/stocks/lscc) LSCC · quiet · Too little evidence to rank firmly · 58% evidence 44.4 out of 100 Growth Capital Valuation Relative
21. [Rambus Inc.](https://www.sectoralpha.in/us/stocks/rmbs) RMBS · quiet · Evidence leans down · 81% evidence 42.7 out of 100 Growth Capital Valuation Relative
22. [STMicroelectronics N.V.](https://www.sectoralpha.in/us/stocks/stm) STM · quiet · Evidence leans down · 64% evidence 42.7 out of 100 Growth Capital Valuation Relative
23. [Tower Semiconductor Ltd.](https://www.sectoralpha.in/us/stocks/tsem) TSEM · quiet · Evidence leans down · 81% evidence 41.8 out of 100 Growth Capital Valuation Relative
24. [SiTime Corporation](https://www.sectoralpha.in/us/stocks/sitm) SITM · quiet · Evidence leans down · 64% evidence 39.8 out of 100 Growth Capital Valuation Relative
25. [Arm Holdings plc](https://www.sectoralpha.in/us/stocks/arm) ARM · quiet · Most evidence points down · 81% evidence 33.1 out of 100 Growth Capital Valuation Relative
26. [GLOBALFOUNDRIES Inc.](https://www.sectoralpha.in/us/stocks/gfs) GFS · quiet · Most evidence points down · 64% evidence 32.3 out of 100 Growth Capital Valuation Relative
27. [Intel Corporation](https://www.sectoralpha.in/us/stocks/intc) INTC · quiet · Most evidence points down · 75% evidence 31.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Semiconductors](https://www.sectoralpha.in/us/sectors/semiconductors), all 27 compared on one page. ## Which companies are close to Silicon Laboratories in size? Silicon Laboratories is the 30th largest of 59 Semiconductors companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Semtech Corporation, Qorvo, Inc. and Rambus Inc. Just below it: Silicon Motion Technology Corporation, Allegro MicroSystems, Inc. and MaxLinear, Inc. ### Semiconductors companies close in size

1. [Semtech Corporation](https://www.sectoralpha.in/us/stocks/smtc) $11.9 billion
2. [Qorvo, Inc.](https://www.sectoralpha.in/us/stocks/qrvo) $10.1 billion
3. [Rambus Inc.](https://www.sectoralpha.in/us/stocks/rmbs) $9.4 billion
4. Silicon Laboratories Inc. $7.4 billion
5. [Silicon Motion Technology Corporation](https://www.sectoralpha.in/us/stocks/simo) $6.8 billion
6. [Allegro MicroSystems, Inc.](https://www.sectoralpha.in/us/stocks/algm) $6.3 billion
7. [MaxLinear, Inc.](https://www.sectoralpha.in/us/stocks/mxl) $5.8 billion

[All 59 Semiconductors companies, largest first](https://www.sectoralpha.in/us/sectors/semiconductors#all-companies)

### Companies close in size in other industries

1. [EPAM Systems, Inc.](https://www.sectoralpha.in/us/stocks/epam) $7.4 billion · Information Technology Services
2. [Alexandria Real Estate Equities, Inc.](https://www.sectoralpha.in/us/stocks/are) $7.4 billion · REIT - Office
3. Silicon Laboratories Inc. $7.4 billion
4. [Zillow Group, Inc.](https://www.sectoralpha.in/us/stocks/zg) $7.4 billion · Internet Content & Information
5. [Vipshop Holdings Limited](https://www.sectoralpha.in/us/stocks/vips) $7.4 billion · Internet Retail

## What else do people ask about Silicon Laboratories? ### What were Silicon Laboratories's latest quarterly results? Silicon Laboratories Inc. reported revenue of $228 M and a net loss of $10.6 M for the Jul 2026 quarter. Earnings per share were −$0.32. The operating margin was −4.7%, 7.2 percentage points higher than a year earlier (as of 3 November 2026). ### What is Silicon Laboratories's market cap? Silicon Laboratories Inc.'s market capitalisation is $7.4 B at a stock price of $222.34. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Silicon Laboratories performing? Silicon Laboratories Inc.'s share price has been rising for 49 weeks. Over the past 13 weeks it has done better than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Silicon Laboratories's stock price go up? This page does not forecast Silicon Laboratories Inc.'s stock price. What it shows instead: the stock price is $222.34, and it has been rising for 49 weeks. Its P/E of 67.1× is higher than 62% of its own last 2 years (as of 3 November 2026). ### Where is Silicon Laboratories in its business cycle? Silicon Laboratories Inc.'s FY26 operating margin was −9.0%, against a 5-year range of −28.3% to 11.6%: the middle of its own range, neither a peak nor a low. The latest quarter was −4.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Silicon Laboratories story? The main question: profits are rising, but only −1% of the last 2 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Silicon Laboratories a stock worth studying right now? What the numbers show: Silicon Laboratories Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- US tech stocks: https://www.sectoralpha.in/us-tech-stocks

This is research, not advice. We’re not SEBI-registered.